{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:53:12Z","timestamp":1762005192037,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijid.2020.02.057","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T11:21:18Z","timestamp":1582975278000},"page":"459-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme"],"prefix":"10.1016","volume":"95","author":[{"given":"Amir","family":"Shroufi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelesh P.","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Nel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahomed-Yunus S.","family":"Moosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halima","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Trivino","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olawale","family":"Ajose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Loyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Ruffell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Van Cutsem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2020.02.057_bib0005","first-page":"17","article-title":"The Treatment Action Campaign and the three dimensions of lawyering: reflections from the rainbow nation","volume":"10","author":"Ahmad","year":"2013","journal-title":"SAHARA J J Soc Asp HIV\/AIDS Res Alliance [Internet]"},{"key":"10.1016\/j.ijid.2020.02.057_bib0010","article-title":"GERMS South Africa Annual Report National Institute for Communicable Diseases.2017GERMS South Africa Annual Report 2017. National Institute for Communicable Diseases","author":"South","year":"2017","journal-title":"National Institute for Communicable Diseases."},{"key":"10.1016\/j.ijid.2020.02.057_bib0015","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/jac\/dkw325","author":"Kneale","year":"2016","journal-title":"J Antimicrob Chemother [Internet]"},{"issue":"11","key":"10.1016\/j.ijid.2020.02.057_bib0020","first-page":"2435","article-title":"Nov","volume":"68","author":"Loyse","year":"2013","journal-title":"Lortholary O"},{"key":"10.1016\/j.ijid.2020.02.057_bib0025","article-title":"Cryptococcal meningitis treatment strategies: a cost-effectiveness analysis in the United States affected by the explosive cost of flucytosine","volume":"23","author":"Merry","year":"2016","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ijid.2020.02.057_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005575","article-title":"Cryptococcal meningitis: A neglected NTD?","author":"Molloy","year":"2017","journal-title":"PLoS Negl Trop Dis [Internet]"},{"key":"10.1016\/j.ijid.2020.02.057_bib0035","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","author":"Molloy","year":"2018","journal-title":"N Engl J Med [Internet]"},{"issue":"8","key":"10.1016\/j.ijid.2020.02.057_bib0040","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis [Internet]"},{"year":"2016","series-title":"National Essential Medicines List Pharmacoeconomics and Budget impact analysis Adult Hospital Level Component : HIV and AIDS","author":"South African National Department of [Internet]","key":"10.1016\/j.ijid.2020.02.057_bib0045"},{"key":"10.1016\/j.ijid.2020.02.057_bib0050","series-title":"South African National Essential Medicine List Adult Hospital Level Medication Review Process Component: HIV and AIDS","first-page":"1","author":"South African National Essential Medicine List Adult Hospital Level Medication Review Process Component","year":"2018"},{"year":"2018","series-title":"cited 2019 Aug 29]","author":"Thepharmaletter","key":"10.1016\/j.ijid.2020.02.057_bib0055"},{"key":"10.1016\/j.ijid.2020.02.057_bib0060","article-title":"Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries","author":"Wilson","year":"2018","journal-title":"Lancet Infect Dis."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220301168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220301168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:54:04Z","timestamp":1761119644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220301168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":12,"alternative-id":["S1201971220301168"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.02.057","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.02.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}